Following positive trial results, retatrutide, a new peptide treatment for addressing adult-onset metabolic disorder, has received regulatory approval from UK’s Medicines and Healthcare Agency (MHRA https://susanamga120944.post-blogs.com/62079037/retatrutide-compound-peptide-united-kingdom-green-light-and-access